Restarting Wegovy After a 3-Month Break: a Step-by-Step Guide

Step 1: understand why three months changes things

Semaglutide works partly by occupying GLP-1 receptors in the gut and brain that regulate hunger and gastric emptying. When you stop, those pathways gradually return to their previous baseline. Three months is enough time for your body to lose most of the physiological adaptation it had built up, tolerance to the GI effects falls away alongside the appetite suppression.

That matters because the titration schedule in the Wegovy SmPC (starting at 0.25 mg and stepping up every four weeks) exists specifically to let your system adjust gradually. If you restarted at 1.7 mg or 2.4 mg because that was your old maintenance dose, your gut would treat it roughly like a first exposure at that strength. The result is usually a sharp return of nausea, vomiting, or diarrhoea, occasionally severe enough to cause dehydration. A reintroduction from the beginning avoids that.

The NHS semaglutide medicines page makes clear that semaglutide is a prescription-only medicine whose dosing schedule should always be followed as directed by your prescriber. That direction applies just as much to restarting as it does to starting for the first time.

Step 2: what your prescriber needs to know

Before you restart, a clinical review is essential. This is not a formality. Three months is long enough for your health to have shifted in ways that are relevant to prescribing: your weight may have changed, a new diagnosis may have emerged, or you may have started other medicines that interact with semaglutide. Our clinical team reviews every restart request individually, a real prescriber reads your history, not a form that auto-approves.

Things worth noting before that consultation: any new medicines (oral contraceptives in particular, see the guidance on absorption and timing), any new diagnoses, your current weight compared with when you stopped, and why you stopped. The reason for stopping sometimes matters: if it was side effects, your prescriber may suggest a slower titration or a longer period at each dose step than the standard four weeks.

If you stopped because of cost, it is worth reading the Wegovy price comparison breakdown, understanding what is included in different services (prescription fees, delivery, aftercare) can shift the maths.

Step 3: the retitration process itself

Assuming you are clinically suitable, retitrating from 0.25 mg is the standard approach after a break of this length. The licensed maintenance pathway runs 0.25 mg → 0.5 mg → 1.0 mg → 1.7 mg → 2.4 mg, with roughly four weeks at each step. At 2.4 mg you are at the established maintenance dose; a higher 7.2 mg dose was approved by the MHRA in early 2026 for some patients, but that decision sits with your prescriber based on your progress and tolerability.

In practical terms: your pen arrives the next working day via DPD in plain, unbranded packaging, nothing on the outside indicates what is inside. You begin at 0.25 mg and your prescriber reviews progress before each dose step. The aim is to reach your previous maintenance dose with as little disruption as possible, usually over twelve to sixteen weeks. The specific considerations involved in restarting Wegovy after two months differ in some respects from a three-month gap, so it is worth understanding how break length affects the approach your prescriber is likely to take.

People often ask whether they will reach the same weight as before. Results in the STEP 1 trial published in the New England Journal of Medicine showed around 15% average weight loss at 2.4 mg over 68 weeks. Individual responses vary, and a restart after a gap tends to follow a similar curve to the original course, though getting back to a previous low may take longer the second time, particularly if weight has been regained. Be realistic about the timeline.

Step 4: what to watch for when you restart

Most people tolerate the low reintroduction doses well, but gastrointestinal symptoms (nausea, loose stools, indigestion, burping) are the most common complaints in the first few weeks at any dose. They tend to settle as your body readjusts. Eating smaller portions, avoiding high-fat meals and staying hydrated all help.

Seek urgent medical attention for severe, persistent stomach pain that spreads to the back, with or without vomiting. This can be a sign of pancreatitis, which the MHRA flagged in a Drug Safety Update in January 2026 as a known but infrequent risk with GLP-1 medicines. Any allergic reaction, difficulty breathing or rapid swelling also requires immediate care. People who are also wondering about restarting semaglutide after a month should be aware that a shorter break may mean less resensitisation, but a prescriber review is still required before resuming. Gaps of different lengths each carry their own clinical nuances, whether you are looking at restarting Wegovy after one month, considering restarting Wegovy after four months, or planning restarting Wegovy after six months, the right dose to return to will depend on how long your system has had to lose its adaptation.

You can report any unexpected side effects through the MHRA Yellow Card scheme. And if you have specific questions about managing symptoms during the restart, our frequently asked questions cover the most common ones, or you can reach the aftercare team through our contact page seven days a week.

When you feel ready to take the next step, starting a free consultation with our prescribers is the right place to begin the restart process properly.